TABLE 2.
Presumed source of infection in 418 patients with Staphylococcus aureus bacteremia by vancomycin MIC status (MIC of <2 μg/ml versus MIC of 2 μg/ml)
| Source | No. (%) of patients with source of infection |
|
|---|---|---|
| Vancomycin MIC < 2 μg/ml (n = 335) | Vancomycin MIC = 2 μg/ml (n = 83) | |
| Community-acquired pneumonia | 12 (3.6) | 2 (2.4) |
| Hospital-acquired pneumonia | 3 (0.9) | 0 (0) |
| Ventilator-associated pneumonia | 3 (0.9) | 0 (0) |
| Implanted prosthetic material | 14 (4.2) | 3 (3.6) |
| Intravascular catheter | 48 (14.3) | 15 (18.1) |
| Abscess | 43 (12.8) | 8 (9.6) |
| Cellulitis | 21 (6.3) | 6 (7.2) |
| Musculoskeletal, bone | 20 (6.0) | 8 (9.6) |
| Musculoskeletal, joint | 10 (3.0) | 1 (1.2) |
| Surgical site infection | 5 (1.5) | 1 (1.2) |
| Urinary tract | 8 (2.4) | 2 (2.4) |
| Wound infection | 9 (2.7) | 0 (0) |
| Unknown | 128 (38.2) | 32 (38.6) |
| Other | 11 (3.3) | 5 (6.0) |